Trial Begins Dosing of ‘Off-the-shelf’ CAR T-cell Therapy for Multiple Myeloma
The first patient has been dosed in a Phase…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreThe first patient has been dosed in a Phase…
Legend Biotech and Janssen’s investigational CAR…
The European Commission (EC) has approved Blenrep (…
The U.S. Food and Drug Administration (FDA) has approved …
Darzalex Faspro (daratumumab and hyaluronidase) significantly extended the…
The online portal HealthTree has opened a free…